These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 31137022

  • 1. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
    Kobayashi S, Myoren T, Kajii T, Kohno M, Nanno T, Ishiguchi H, Nishimura S, Fukuda M, Hino A, Fujimura T, Ono M, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Okuda S, Yoshiga Y, Kawano R, Yano M.
    Cardiology; 2019; 142(4):195-202. PubMed ID: 31137022
    [Abstract] [Full Text] [Related]

  • 2. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
    Kobayashi S, Susa T, Tanaka T, Murakami W, Fukuta S, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Okamura T, Yano M, Matsuzaki M.
    Circ J; 2012; 76(7):1646-53. PubMed ID: 22481100
    [Abstract] [Full Text] [Related]

  • 3. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S, Murakami W, Myoren T, Tateishi H, Okuda S, Doi M, Nao T, Wada Y, Matsuzaki M, Yano M.
    Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
    [Abstract] [Full Text] [Related]

  • 4. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
    Adachi T, Sato A, Baba M, Hiraya D, Hasegawa T, Kuroki K, Hoshi T, Aonuma K.
    Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
    Shinohara M, Wada R, Yano K, Akitsu K, Koike H, Kinoshita T, Suzuki T, Fujino T, Ikeda T.
    Int Heart J; 2020 Sep 29; 61(5):944-950. PubMed ID: 32921677
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T, Shimizu K, Kawashima O, Kamiyoshihara M, Nagashima T, Ibe T, Takeyoshi I.
    J Clin Pharm Ther; 2012 Aug 29; 37(4):431-5. PubMed ID: 22059486
    [Abstract] [Full Text] [Related]

  • 8. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
    Sumitomo N, Horigome H, Miura M, Ono H, Ueda H, Takigiku K, Yoshimoto J, Ohashi N, Suzuki T, Sagawa K, Ushinohama H, Takahashi K, Miyazaki A, Sakaguchi H, Iwamoto M, Takamuro M, Tokunaga C, Nagano T, Heartful Investigators.
    J Cardiol; 2017 Sep 29; 70(3):232-237. PubMed ID: 28073682
    [Abstract] [Full Text] [Related]

  • 9. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    Yamashita T, Saitoh T, Matsushita M.
    J Cardiol; 2015 Jul 29; 66(1):69-72. PubMed ID: 25454208
    [Abstract] [Full Text] [Related]

  • 10. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
    Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, Hori M, J-Land Investigators.
    Circ J; 2013 Jul 29; 77(4):908-16. PubMed ID: 23502991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study.
    Sakai M, Jujo S, Kobayashi J, Ohnishi Y, Kamei M.
    J Cardiothorac Surg; 2019 Jul 25; 14(1):145. PubMed ID: 31345252
    [Abstract] [Full Text] [Related]

  • 15. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
    Takahashi S, Fujii Y, Hoshi T, Inomata S, Miyabe M, Toyooka H.
    Can J Anaesth; 2000 Mar 25; 47(3):265-72. PubMed ID: 10730740
    [Abstract] [Full Text] [Related]

  • 16. [Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
    Uehara K, Ueyama K, Ito H, Fukuda T, Sasaki K, Abe T, Nakane E, Miyamoto S, Haruna T, Inoko M, Nohara R.
    Kyobu Geka; 2010 Mar 25; 63(3):188-91. PubMed ID: 20214345
    [Abstract] [Full Text] [Related]

  • 17. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T, Sato A, Nishina H, Kakefuda Y, Wang Z, Noguchi Y, Aonuma K.
    J Cardiol; 2012 Oct 25; 60(4):252-6. PubMed ID: 22835733
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
    Taenaka N, Kikawa S.
    Am J Cardiovasc Drugs; 2013 Oct 25; 13(5):353-64. PubMed ID: 23818039
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience of landiolol for the treatment of intraoperative rapid atrial fibrillation].
    Suzuki Y, Furuhashi K, Maruyama K.
    Masui; 2004 Apr 25; 53(4):411-3. PubMed ID: 15160669
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    Iwahashi N, Kirigaya J, Abe T, Horii M, Takahashi H, Hanajima Y, Kimura Y, Minamimoto Y, Okada K, Matsuzawa Y, Hibi K, Kosuge M, Ebina T, Tamura K, Kimura K.
    J Cardiol; 2022 Jan 25; 79(1):21-29. PubMed ID: 34565687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.